Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia negatively affects quality of life, especially in younger, less educated, single, and rural individuals.

Human hair is made up of different keratins, some strong and some weak, with specific types appearing at various stages of hair growth.

Caffeine may help reduce stress-induced hair loss.

Trichoscopy is useful for detecting and monitoring androgenetic alopecia.

Advanced male pattern baldness affects the back of the scalp, reducing hair follicles.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Trichoscopy, a hair loss evaluation technique, found that people with Androgenetic Alopecia have more thin hairs, yellow dots, and perifollicular discoloration than healthy individuals.

Female pattern baldness may indicate a higher risk of coronary artery disease.

AC5 improves hair loss and hair quality with high satisfaction rates.

CGF from platelets helps hair regrowth in people with androgenetic alopecia.

Dysregulated lipid metabolism may play a role in male pattern baldness.

Platelet-rich plasma therapy improves hair growth and health in androgenetic alopecia better than some FDA-approved treatments.

Partially bald areas in Indian AGA patients still have hair growth cells, suggesting early treatment is best.

FAPD in children may not depend on androgens and should be treated with anti-inflammatory measures and minoxidil.

Targeting multiple pathways may improve treatments for androgenetic alopecia.

Heat-treated Limosilactobacillus fermentum with menthol, salicylic acid, and panthenol promotes hair growth and balances scalp microbiome in people with androgenetic alopecia.

The 1565 nm non-ablative fractional laser is more effective and satisfying than 5% minoxidil for treating hair loss.

Both minoxidil-spironolactone and minoxidil-finasteride treatments work for hair loss, but minoxidil-spironolactone is slightly more effective, especially in women.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

The scalp microbiome is more diverse and may be more important in hair loss than the gut microbiome.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

More personalized and effective treatments for androgenetic alopecia are needed.

Men with baldness, ear creases, and hairy ears have a higher risk of heart disease.

Setipiprant did not significantly improve hair growth in men with hair loss.

Topical finasteride is an effective and safer treatment for male hair loss.

Topical 5% minoxidil is safe and effective for treating hair loss in Korean men.

Hair patterns in mice are controlled by both a global system dependent on Fz6 and a local self-organizing system.

Minoxidil can reduce functions related to androgen receptors.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.